TAKHZYRO is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥12 years of age.

Mobile site search icon.
Mobile navigation icon.

TAKHZYRO is indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients ≥12 years of age.

TAKHZYRO Quick Start PROGRAM

Takeda will provide eligible patients with immediate access to TAKHZYRO at no cost during potential delays in commercial insurance coverage determinations.* Complete the 3 simple steps below, including the Quick Start Form, to get your patient started.

3 simple steps to get your patients started right away

1

Print and fill out these 2 forms completely (here is an annotated start form for reference):

2

Fax BOTH forms to OnePath® at
1-855-ONEPATH (1-855-663-7284)

3

Let OnePath take it from there

Once BOTH forms are received by OnePath:

Your patient’s dedicated Patient Support Manager will call your patient promptly to:

  • Confirm all forms are complete
  • Coordinate shipment of TAKHZYRO

The benefits investigation will be conducted. Prior authorization/appeal, if required, will begin. We've included a checklist of what we suggest keeping on-hand for the benefits investigation process.

A 1-month supply of TAKHZYRO will be shipped to your patient once eligibility requirements have been confirmed and the specialty pharmacy verifies the prescription with your office. At this time, a specially trained nurse will call the patient to schedule self-administration training.

Once your patient's commercial insurance coverage for TAKHZYRO is approved, he/she will no longer be eligible for the Quick Start Program.

Once eligibility has been confirmed, a 1-month supply of TAKHZYRO will be shipped to your patients. Patients are eligible for up to 2 months of product at no cost, with the potential for an approval process for continued supply of the product after the second month.

Note that insurance companies sometimes require additional documentation to authorize coverage for TAKHZYRO, which could include:

Statement of Medical Necessity

Letter of Intent to Treat

Coverage Denial Letter

Formulary Exception Letter

Claim Denial Letter

OnePath® logo.

Explore OnePath® support

Learn more about product support available through OnePath.

View Services

Office Resource Kit

Find materials and forms to help get patients started on TAKHZYRO.

See Resources